References
- CampodonicoAColladoERicciRPappaHSegallAPizzornoMTDissolution test for silymarin tablets and capsulesDrug Dev Ind Pharm200127326126511291206
- TedescoDTavaAGallettiSEffects of silymarin, a natural hepatoprotector, in periparturient dairy cowsJ Dairy Sci20048772239224715328238
- MohamedESGamalESTarekMIComparison of early treatment with low doses of nilotinib, imatinib and a clinically relevant dose of silymarin in thioacetamide-induced liver fibrosisEur J Pharmacol20016702593600
- KvasnickaFBibaBSevcikRVoldrichMKratkaJAnalysis of the active components of silymarinJ Chromatogr A2003990123924512685603
- WuJWLinLCHungSCChiCWTsaiTHAnalysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability applicationJ Pharm Biomed Anal200745463564117692492
- ComoglioATomasiAMalandrinoSPoliGAlbanoEScavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicalsBiochem Pharmacol1995508131313167488251
- WuLQiaoYLWangLNA self-microemulsifying drug delivery system (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in ratsAAPS PharmSciTech Epub201526
- DuHHYongIKKwanHCA novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activityJ Microencapsul201431761962624766208
- CaoXFuMWangLOral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticlesActa Biomater2012862104211222343518
- AngelicoRCeglieASaccoPColafemminaGPhyto-liposomes as nanoshuttles for water-insoluble silybin–phospholipid complexInt J Pharm2014471117318124858381
- HeJHouSLuWPreparation, pharmacokinetics and body distribution of silymarin-loaded solid lipid nanoparticles after oral administrationJ Biomed Nanotechnol200732195202
- ShangguanMZLuYQiJPHanJBinary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarinJ Biomater Appl201428688789624008629
- KumarNRaiAReddyNDRajPVSilymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cellsPharmacol Rep201466578879825149982
- NiuMTanYGuanPEnhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic studyInt J Pharm2014460111913024275447
- MikovMFawcettJPKuhajdaKKevresanSPharmacology of bile acids and their derivatives: absorption promoters and therapeutic agentsEur J Drug Metab Pharmacokinet200631323725117136862
- YuJNZhuYWangLEnhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micellesActa Pharmacol Sin201031675976420523347
- GuanPPLuYQiJPNiuMMEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomedicine2011696596597421720508
- ChenGYLiDHJinYDeformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechinDrug Dev Ind Pharm201440226026523356860
- YangKWJosephTDUlrichSSAlfredFFast high-throughput screening of temoporfin-loaded liposomal formulations prepared by ethanol injection methodJ Liposome Res2012221314121682653
- YinFGuoSYGanYZhangXXPreparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factorInt J Nanomedicine201491665167624729702
- PankajRKWonkyungCHee-JunPJeong-SookPCharacterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham methodInt J Nanomedicine2013836537723378759
- KimMSJinSJKimJSPreparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) processEur J Pharm Biopharm200869245446518359211
- PasqualiIBettiniRGiordanoFSupercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticalsAdv Drug Deliv Rev200860339941017964684
- AntonioTEvaMMiguelAPrecipitation of tretinoin and acetaminophen with solution enhanced dispersion by supercritical fluids (SEDS)Powder Technol2012217177188
- RagoneseRMackaMHughesJPetoczPThe use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in a pharmaceutical formulationJ Pharm Biomed Anal2002276995100711836062
- BahiaAPAzevedoEGFerreiraLAFrézardFNew insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent markerEur J Pharm Sci2010391909619903526
- NiuMLuYHovgaardLWuWLiposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization and improved protection against enzymatic degradationInt J Nanomedicine201161155116621822379
- HuSNiuMHuFIntegrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal mediaInt J Pharm2013441169370023089580
- LiuDHuHLinZQuercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivoJ Photochem Photobiol B201312781723933244
- KhodadoustSHadjmohammadiMDetermination of N-methylcarbamate insecticides in water samples using dispersive liquid–liquid microextraction and HPLC with the aid of experimental design and desirability functionAnal Chim Acta2011699111311921704765
- EsfandiariNGhoreishiSMSynthesis of 5-fluorouracil nanoparticles via supercritical gas antisolvent processJ Supercrit Fluids201384205210
- WangJChenJYangYMicronization of titanocene dichloride by rapid expansion of supercritical solution and its ethylene polymerizationJ Supercrit Fluids2005332159172
- HaoJWangFWangXDevelopment and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite designEur J Pharm Sci201247249750522820033
- RahmanZZidanASHabibMJKhanMAUnderstanding the quality of protein loaded PLGA nanoparticles variability by Plackett–Burman designInt J Pharm2010389118619420038446
- CuiFDTaoAJCunDMZhangLQShiKPreparation of insulin loaded PLGA-Hp55 nanoparticles for oral deliveryJ Pharm Sci200796242142717051590
- García-RodriguezJJde la Torre-IglesiasPMVegas-SánchezMCTorrado-DuránSBolás-FernándezFTorrado-SantiagoSChanged crystallinity of mebendazole solid dispersion: improved anthelmintic activityInt J Pharm20014031232820934497
- SemaltyASemaltyMSinghDRawatMSMPreparationand characterization of phospholipid complexes of naringenin for effective drug deliveryJ Incl Phenom Macrocycl Chem2010673–4253260
- HaeriASadeghianSRabbaniSAnvariMSBoroumandMADadashzadehSUse of remote film loading methodology to entrap sirolimus into liposomes: preparation, characterization and in vivo efficacy for treatment of restenosisInt J Pharm20114141162721554939
- NiuMLuYHovgaardLHypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered doseEur J Pharm Biopharm201281226527222369880
- DialEJRooijakkersSHDarlingRLRomeroJJLichtenbergerLMRole of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranesJ Gastroenterol Hepatol200823343043617868333
- HildebrandABeyerKNeubertRGaridelPBlumeATemperature dependence of the interaction of cholate and deoxycholate with fluid model membranes and their solubilization into mixed micellesColloids Surf B Biointerfaces2003324335351
- PorterCJHTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
- AndrieuxKForteLLesieurSPaternostreMOllivonMGrabielle-MadelmontCSolubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile saltEur J Pharm Biopharm200971234635518835441
- CevcGVierlUMazgareanuSFunctional characterisation of novel analgesic product based on self-regulating drug carriersInt J Pharm20083601182818524509